Your browser doesn't support javascript.
loading
SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers
Ann-Sofie Rudberg; Sebastian Havervall; Anna Manberg; August Jernbom Falk; Katherina Aguilera; Henry Ng; Lena Gabrielsson; Ann-Christin Salomonsson; Leo Hanke; Benjamin Murell; Gerald McInerney; Jennie Olofsson; Eni Andersson; Cecilia Hellstrom; Shaghayegh Bayati; Sofia Bergstrom; Elisa Pin; Ronald Sjoberg; Hanna Tegel; My Hedhammar; Mia Phillipson; Peter Nilsson; Sophia Hober; Charlotte Thalin.
Afiliação
  • Ann-Sofie Rudberg; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
  • Sebastian Havervall; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
  • Anna Manberg; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • August Jernbom Falk; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Katherina Aguilera; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
  • Henry Ng; Department of Medical Cell Biology, Uppsala University, SciLifeLab, Uppsala, Sweden
  • Lena Gabrielsson; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
  • Ann-Christin Salomonsson; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
  • Leo Hanke; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  • Benjamin Murell; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  • Gerald McInerney; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  • Jennie Olofsson; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Eni Andersson; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Cecilia Hellstrom; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Shaghayegh Bayati; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Sofia Bergstrom; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Elisa Pin; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Ronald Sjoberg; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Hanna Tegel; Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
  • My Hedhammar; Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
  • Mia Phillipson; Department of Medical Cell Biology, Uppsala University, SciLifeLab, Uppsala, Sweden
  • Peter Nilsson; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Sophia Hober; Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
  • Charlotte Thalin; Department of clinical medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20137646
ABSTRACT
BackgroundSARS-CoV-2 may pose an occupational health risk to health care workers, but the prevalence of infections in this population is unknown. We examined the seroprevalence of SARS-CoV-2 antibodies among health care workers at a large acute care hospital in Stockholm, Sweden. We determined correlations between seroprevalence, self-reported symptoms and occupational exposure to SARS-CoV-2. Methods and findingsAll employees at Danderyd Hospital (n=4375) were invited to participate in a cross-sectional study. 2149 employees from all hospital departments were enrolled in the study between April 14th and May 8th 2020. Study participants completed a questionnaire consisting of symptoms compatible with SARS-CoV-2 infection since January 2020 and occupational exposure to patients infected with SARS-CoV-2. IgG antibodies against SARS-CoV-2 were analyzed using a multiplex assay evaluated to have 99.4% sensitivity and 99.1% specificity. The over-all seroprevalence among 2149 participants was 19.1% (n=410). There was no difference in age or sex between seropositive and seronegative participants. The symptoms with the strongest correlation to seroprevalence were anosmia and ageusia, with odds ratios of 28.4 (p=2.02*10^-120) and 19.2 (p=1.67*10^-99) respectively. Seroprevalence was strongly associated with patient-related work (OR 2.9, p=4.24*10^-8), covid-19 patient contact (OR 1.43, p=0.003), and occupation as assisting nurse (OR 3.67, p=2.16*10^-9). ConclusionThese results demonstrate that anosmia and ageusia should be included in screening guidance and in the recommendations of self-isolation to reduce further spread of SARS-CoV-2. The results furthermore imply an occupational health risk for SARS-CoV-2 infection among hospital workers. Continued measures are warranted to assure healthcare worker safety and reduce transmission from health care settings to the community during the covid-19 outbreak.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Estudo prognóstico / Rct Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Estudo prognóstico / Rct Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...